Name: Olema Pharmaceuticals, Inc. (OLMA) Balance Sheet
Creator: FinSpry

Olema Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Olema Pharmaceuticals, Inc. (OLMA) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	139.48	68.54	23.70	287.25	338.55
Short-Term Investments	294.61	193.27	180.72	273.44	0.00
Cash & Short-Term Investments	434.09	261.81	204.42	287.25	338.55
Accounts Receivable	2.12	0.67	0.32	0.13	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.37	2.35	2.64	0.22	3.01
Total Current Assets	438.47	266.51	208.90	290.69	342.14
Non-Current Assets
Property, Plant & Equipment (Net)	2.06	3.26	2.50	4.72	0.08
Intangible Assets	0.68	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.70	7.17	4.25	0.54	0.51
Total Non-Current Assets	12.51	2.29	6.75	5.26	0.00
Total Assets	450.98	276.95	215.65	295.95	342.72
Current Liabilities
Accounts Payable	4.46	2.70	0.37	0.02	0.72
Short-Term Debt	1.17	0.00	0.00	0.00	0.00
Accrued Liabilities	30.42	17.86	15.09	4.02	3.43
Other Current Liabilities	36.09	17.94	15.16	8.07	0.24
Total Current Liabilities	41.76	21.62	16.55	9.02	4.59
Non-Current Liabilities
Long-Term Debt	0.26	1.43	1.55	2.36	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.26	1.43	1.55	2.36	0.00
Total Liabilities	42.02	23.05	18.10	11.38	4.59
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.00	0.00
Retained Earnings	-435.11	-305.63	-208.98	-104.34	-33.09
Accumulated Other Comprehensive Income	0.14	0.35	-1.81	-0.15	0.00
Additional Paid-in Capital	843.92	559.18	408.33	388.90	0.00
Shares Outstanding	74.31	54.99	40.29	39.80	0.00
Total Stockholders' Equity	408.96	253.90	197.55	284.57	338.14
Total Liabilities & Equity	450.98	276.95	215.65	295.95	0.00